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Abstract
Low back pain (LBP) affects up to 80% of the global population at some point during
their life. The costs associated with LBP are estimated at $100 billion per year, putting
significant strains on our healthcare system. As intervertebral disc (IVD) herniation is
one of the major causes of LBP we decided to focus on herniation facilitated
inflammatory responses, where damage caused by herniation triggers an innate
immune response which likely results in pain, inflammation, and recruitment of
specialized innate immune cells like macrophages to the affected area. Since the role of
the inflammatory response is relatively uncharacterized in the IVD, the goals of this
research were to 1) characterize this early innate immune response by isolating annulus
fibrosus (AF) and nucleus pulposus (NP) cells from rat-tail IVDs and growing them in
culture, 2) determine the pattern recognition receptors (PRR) repertoire of these cells
used to initiate inflammation and 3) identify their ability to mount an inflammatory
response following an appropriate damage associated molecular pattern (DAMP)
stimulus. Furthermore we determined the effects of this inflammatory response at the
tissue level on the biomechanical properties of functional spine units collected from rattails. During the course of this experiment we discovered that changes in cytokine
production at the cellular level as a result of DAMP stimulation and the resulting
inflammatory response had tangible consequences to IVD biomechanics at the tissue
level. Injecting discs with 5.0 μg/mL of decorin, while showing no effects 24 hours post
injection, resulted in significant increases in IVD compliance 6 days post injection
(p=0.016) compared to PBS injected controls. Increased laxity as a result of DAMP
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mediated inflammation supports our hypothesis of IVD degeneration as a condition of
the inflammatory response. This will open new avenues exploring the possibility of
novel therapeutics targeting upstream PPRs stopping inflammation before the
degenerative cascade takes effect.
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Chapter 1. Introduction and Literature Review
Low back pain (LBP) affects 1 in 5 people at any given time, with over 85% of
the population experiencing some sort of lower back pain in their lifetime
(Andersson, 1998; Walker, 2000). Injury due to LBP may lead to high medical costs
for treatment, and lost income and productivity when disability leave is required.
The costs associated with LBP are estimated to be approximately $100 billion / year
in the US alone (Katz, 2006). A major cause of LBP is mechanical compression of the
nerve root during injury, however the role of the innate immune response and how
it causes low back pain has not been fully investigated (Al-Obaidi & Mahmoud, 2014;
Atlas & Deyo, 2001; Splittstoesser et al., 2012). Therefore this thesis aimed to
determine exactly what components of the innate immune response occur following
IVD herniation. This will allow us to better understand the causes of LBP so more
effective treatments can be developed.

1.1 Prevalence of Low Back Pain
Recent reports suggest that almost 20% of patients experiencing LBP
develop chronic conditions lasting 3 or more months and 40% of patients reporting
lifelong incidence of reoccurring episodes (Hoy et al., 2012). Injury due to LBP has
been shown to cause significant economical impacts not only due to high medical
costs for treatment, but also diversion of medical resources, physicians time, and the
lost income when disability leave is required. The total costs associated with LBP
are estimated to be approximately $100 billion/year in the US alone (Katz, 2006).
Despite these costs, LBP still has relatively few treatment options available with the
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majority of cases healing themselves with rest and time. Notwithstanding, LBP
related injuries are the second leading cause of physician visits and third major
reason for surgical intervention (Andersson, 1998).

1.2 Causes of Low Back Pain
Despite LBP prevalence and its symptoms reaching every demographic –
crossing age, gender, and racial groups, little consensus has been reached regarding
the origin of LBP. Instead, symptoms have been noted to stem from a number of
triggering factors, which can be roughly broken down into three main groups. These
include biological sources, such as nutrition, aging, and genetics (Adams & Roughley,
2006a; Kadow et al., 2015); anatomical sources, including nerve roots, muscle,
bones and joints, organs within the abdominal cavity, and IVDs themselves (Allegri
et al., 2016); and finally neuropathic causes which are influenced by psychological
factors such as stress, anxiety, or depression (Besen et al., 2015; Deyo et al., 2015).
Adding to the complication of diagnosing LBP is that magnetic resonance imaging
(MRI) of both symptomatic and asymptomatic patients are only weakly related at
best to described symptoms (Allegri et al., 2016). Furthermore cross-sectional
studies have found that 36% of asymptomatic patients over the age of 60 had
herniated IVDs, 21% had spinal stenosis, and more than 90% had bulging or
degenerated IVDs (Boden et al., 1990). Due to the high prevalence of IVD herniation
and its ability to accelerate the degeneration of the IVD following injury, further
study into this area is needed (Fardon et al., 2014).
In addition to the causes previously listed, degeneration of the IVD is one of
the major contributors to LBP. However it is still unknown why some degeneration
Matthew Guerreiro 2018©
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cases remain asymptomatic whilst others lead to pain. Furthermore not only is
degeneration a natural occurrence developing with age but also a symptom of injury
to the IVD. Unsurprisingly, 81.1% of patients in one study who reported LBP also
had associated IVD degeneration (Luoma et al., 2000).

1.3 Anatomy of the IVD
The human IVD can be broken down into four general regions; the AF forms
the outer layer of the IVD and can be further subdivided into the outer AF and the
inner AF which forms the transition zone between the AF and NP regions, the
gelatinous NP at the center of the IVD, and finally the vertebral end plates
separating the IVD from the vertebral body (Figure 1; Tomaszewski et al., 2015).
With an average cross sectional area of 1727 mm2 and IVD height of 9.93 mm, the
IVD accounts for approximately 30% of the total length of the spinal column
(O’Connell et al., 2007; Urban & Roberts, 2003). As the IVD’s primary function is to
distribute forces and transfer loads across the spine it relies on each region having a
unique cellular makeup, and distinct morphological and mechanical properties to
handle the complex, multidirectional mechanical forces to which the spine is
regularly exposed. In addition to this the IVD is both aneural and avascular. This
makes movement of cellular resources and signals across the IVD more difficult and
relies heavily on the diffusion of molecules through the AF and vertebral endplates
from neighboring vessels.
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Figure 1: Structure and Function of the IVD
A diagram depicting the different regions of the IVD, The NP, primarily composed of
a highly hydrated gel made of proteoglycan and hyaluronan long chains with
randomly organized type II collagen fibres and radially organized elastin fibres. In
contrast the AF is comprised of mostly type I collagen fibres in the outer region
transitioning to type II collagen fibres in the inner region. The AF is comprised
angled lamellar rings lying parallel with each other. (Tomaszewski et al., 2015)
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1.4.1 The Nucleus Pulposus
The NP is primarily composed of a highly hydrated gel made of proteoglycans
and hyaluronan long chains. Whilst proteoglycan concentration varies between
species, the mammalian NP typically expresses approximately 90% aggrecan with
lesser quantities of decorin, versican, and other proteoglycans (Colombier et al.,
2014). The hyaluronan long chains carry a negative charge responsible for creating
osmotic gradients, drawing water into the IVD and maintaining the hydrostatic
pressure within the IVD. It is this osmotic gradient which allows the IVD to standup
to extreme repetitive stresses placed on the spine. Allowing the IVD to evenly
distribute mechanical forces across the entire surface area of the IVD facilitates this
phenomenon. Embedded within the gelatinous matrix are randomly organized type
II collagen fibers and radially organized elastin fibers which further contribute to
the IVD’s elasticity and its ability to dissipate loads (Figure 1) (Adams & Roughley,
2006a; Hickey & Hukins, 1980; Tomaszewski et al., 2015). Cells in the NP are
considered to be highly specialized due to the avascular nature of the IVD leading to
a hypoxic environment of approximately 1% O2 within the NP region of the IVD
(Risbud et al., 2010). The NP cells are known to have a heterogeneous morphology
with the majority of cells taking on a notochordal-like morphology in mammals,
however this morphology general changes to a more chondrocyte like morphology
by approximately 3 month in humans.
1.4.2 The Outer Annulus Fibrosus
The outer AF is comprised of 15 -20 lamellae or layers of tissue arranged
similarly to tree rings. Primarily made of type I collagen fibers (and some type II
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collagen fibers), the fibers are highly organized lying parallel with each other to
maximize strength. The orientation of the collagen fibers alternate in direction with
each successive lamellar layer (Pezowicz et al., 2005). In addition to the large
proportion of collagen fibers, some elastin fibers and proteoglycans, such as decorin,
are also found in the AF region of the IVD though not nearly in as high
concentrations as the NP. The AF’s ability to attract water and maintain hydrostatic
pressure via the release of proteoglycans in the AF ECM are necessary to opposing
compressive forces on the IVD just as previously described in the NP.
1.4.3 The Inner Annulus Fibrosus
The inner AF expresses a mixture of characteristics seen in the outer AF and
NP regions of the IVD hence why it is commonly referred to the transitional region
between the AF and NP. As with the outer AF the cells of the inner AF are
fibroblastic in nature though they exhibit a rounded chondrocyte like morphology
analogous with cells of the NP.
Lamellar structural integrity is maintained by a highly complex interaction
between both inter-lamellar and intra-lamellar matrices. Connective tissue found
within each lamellae helps maintain adhesion between adjacent collagen bundles.
Connective tissues between the individual lamellae known as intra-lamellar
matrices help prevent delamination or separation of the lamellae. This not only
gives this region of the IVD its highly dense and fibrous properties, but also its
strength, allowing it to withstand repeated compressive forces from daily activity
(Figure 1) (Hickey & Hukins, 1980; Le Maitre et al., 2004; Tomaszewski et al., 2015;
Zhao et al., 2007; Urban & Roberts, 2003).
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Cells of the AF maintain a fibroblastic-like morphology throughout life invivo
as well as in culture. This is in contrast to NP cells, which are known to change their
morphology from notochordal like cells, stemming from their notochordal
embryonic origins, to a rounded chondrocyte like morphology at approximately 3
months of age. In culture the NP cells are seen to change their morphology from
round notochord like cells to elongate spindle shaped cells (Chen et al., 2013)
1.4.4 The Vertebral End Plate
Each IVD is sandwiched between plates of hyaline cartilage-providing a
barrier between the IVD and the end of the adjacent vertebrae. This region of the
IVD shows similar characteristics to the rest of the IVD, such as being both avascular
and aneural, as well as being able to assist in distributing forces across the IVD and
maintaining the pressure of the NP (Raj, 2008; Lotz et al., 2013). The vertebral end
plate is relatively thin compared to other IVD regions thus allowing diffusion of
nutrients, small molecules, and waste between the avascular IVD and the
vascularized vertebral bodies (Lotz et al., 2013). However the region also serves as
an important barrier from surrounding tissue and blood vessels, helping to maintain
the immunoprivileged properties of the IVD. During an innate immune response the
VEP would not only aid in the promoting the inflammatory process by producing
cytokines of its own, it would also facilitate IVD repair by allowing nutrients to cross
into the IVD from the nearby vascularized bone (Lotz et al., 2013).

Whilst the NP, inner AF, and outer AF are considered to be significantly
differentiated and thus distinguishable in healthy adult IVDs, a consequence of
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ageing and natural IVD degeneration is the blurring of boundaries between the AF
and NP along with the loss of proteoglycans and type I collagen the IVD also begins
to lose its strength and ability to distribute forces increasing the probability of
injuries like herniation.

1.4 Injury to the IVD
IVD injury is a multifaceted issue with injury to the IVD presenting as two
primary forms, the first is age-related injury stemming from the natural
degeneration the IVD undergoes over time. The second comes from physical injury
to the IVD with the most prevalent type of injury being herniation. In either case
injury, whether degenerative or physical, can lead to altered loading and dispersion
of forces across the IVD (Iatridis et al., 2009). This can prevent healing in the IVD by
aggravating inflammation, but can also lead to damage of other IVDs particularly
when abnormal loading of involved. Overall IVD injury is considered to be a result of
multiple factors, any of which can predispose or hasten the chances an individual
experiences IVD damage. Unsurprisingly, the constant stresses placed on the spine
in conjunction with lifestyles promoting; poor spine posture, increased obesity
rates, and poor nutrition all increase risk of IVD injury. Similarly, workplaces
demanding ever increasing levels of productivity, higher physical demands in the
way of increasing load, repetitive movements, and abnormal loading patterns, have
all been listed as possible causes raising the number of low back related injuries
seen each year (Adams & Roughley, 2006b; Chan et al., 2006; Kadow et al., 2015;
Zhao et al., 2007; Urban & Roberts, 2003). In addition to the plethora of factors that
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lead to injury, the IVD’s avascular nature means that repair to the IVD is limited by
nutrients available and how quickly they can be replaced via diffusion from the
surrounding tissue and blood vessels.
1.5.1 Herniation
Herniation of the IVD is defined as when the inner NP migrates through the
AF layer and is often characterized based on severity (Adams & Roughley, 2006a;
Gregory & Callaghan, 2011). The first stage of herniation, called protrusion, involves
the partial migration of the NP layer into the AF. The second stage, extrusion, is
characterized when the NP completely migrates though the AF and is visible on the
exterior of the IVD. The third stage, sequestration, is when herniated material (NP
and/or AF) detaches from the IVD and becomes free floating (Figure 2) (Gregory &
Callaghan, 2011; Guerin, 2006). Depending on the severity of the herniation, IVDs
may only be subject to protrusion of the NP into the AF, or may experience multiple
stages of herniation as the complexity and severity of the case increases. IVDs that
have advanced degeneration are less prone to this sort of injury as they lack the
ability to maintain sufficient hydrostatic pressure to force the NP into the AF
(Schmidt et al., 2007).
1.4.1 IVD Degeneration
Due to the prevalence of IVD injury it is difficult to determine if degeneration
originates from injury, for example IVD herniation, or if it is primarily age related
(Adams & Roughley, 2006b; Zhao et al., 2007). In most cases, degeneration of the
IVD leads to a reduction in the IVD’s ability to distribute forces. This can be due to
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loss of proteoglycans in the NP, changes to ECM morphology, failure to repair
damaged IVD ECM, or improper IVD loading due to other age-related
symptoms(Adams & Roughley, 2006b). Degeneration compromises the IVD’s ability
to distribute mechanical loads, which can put increased strain on the IVD and
exacerbate inflammation within the IVD (Zhao et al., 2007).
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Figure 2: Stages of Intervertebral Disc Herniation
The first stage of herniation, called prolapse, involves the partial migration of
the NP layer into the AF. The second stage, extrusion, is characterized when the NP
completely migrates though the AF and is visible on the exterior of the IVD. The
third stage, sequestration, is when herniated NP material detaches from the IVD and
becomes free floating (Dawson & An, 2016).
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1.6. The Innate Immune Response
The innate immune system is the body’s first line of defense against infection. It
consists of constitutive immunity and induced immunity. Constitutive immunity
includes natural barriers like the skin, whilst induced immunity uses pattern
recognition receptors (PRRs) to detect damage associated and pathogen associated
molecular patterns (DAMPs and PAMPs) and initiate appropriate immune
responses. Due to the lack of vascularization of the IVD and thus the lack of access,
particularly to the inner NP layer, the IVD is considered to be one of the body’s
major immunoprivileged sites; essentially excluding the adaptive immune response
from the IVD (Clouet et al., 2009; Hoy et al., 2012). Exclusion of the adaptive
immune response forces the tissue to rely on innate immunity to respond to
damage. Though it is not understood exactly how this innate immune response
progresses, production of pro-inflammatory cytokines following IVD damage has
been well-documented and is believed to cause further IVD degeneration
(Colombini et al., 2008; Smith et al., 2011; Walker & Anderson, 2004; Zhao et al.,
2007).

1.6.1 Pattern Recognition Receptors
PRRs are proteins expressed by every cell and facilitate both intracellular
communication as well as cell-to-cell communication (Kawai & Akira, 2010). Each
cell type expresses a different repertoire of PRRs dictating the scope of their ability
to detect different molecules. The molecules detected by PRRs can be generally
broken down into two main categories: PAMPs, which are foreign elements to the
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host such as bacterial cell wall components like lipopolysaccharide (LPS; Kawai &
Akira, 2010)), and host-derived molecular patterns linked to cell damage/death,
also known as DAMPs (Babelova et al., 2009; Pétrilli et al., 2007). These include
degraded ECM, uric acid, extracellular DNA or RNA, extracellular ATP, amongst
other compounds (Pétrilli et al., 2007). As each cell type expresses a different
collection of PRRs and the exact PRR expression profile of AF and NP cells has never
been fully characterized, we did not know which DAMPs AF and NP cells were able
to identify during a tissue damage event such as herniation. The PRR whose
expression was measured in the AF and NP cells of this study include: TLR 1-10,
RIG-I, MDA-5, NLRP-3, DAI, AIM2, Mincle and Dectin.
1.6.2 Mechanism of Inflammation
Some TLRs, such as TLR 2 and 4, are located on the surface of the cell and can
detect short leucine rich proteoglycans or SLRPs, which can act as a DAMP during
IVD herniation (Moreth et al., 2012). Binding a DAMP to its corresponding PRR
induces a signal cascade. For example, activation of TLR2/4 activates a signaling
cascade via the adapter molecule myeloid differentiation factor 88 (MyD88). MyD88
will trigger a kinase dependent signaling cascade through the cell resulting in
activation of the transcription factors, NF-κB and AP-1, protein complexes that
control DNA transcription and cytokine production (Nilsen et al., 2015). Proinflammatory cytokines like IL-1, IL-4, IL-6, IL-8 and TNF-α expression will be
regulated by these transcription factors. Similarly, chemokines, cytokines which
induce chemotaxis and attract specialized immune cell to the site of infection, like
macrophage inflammatory protein 2 (MIP2), monocyte chemoattractant protein 1
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(MCP1), and regulated on activation, normal T cell expressed and secreted
(RANTES) are also regulated by the transcription factors NF-κB and AP-1. As such
cytokines are immensely diverse in their function and are capable of eliciting a
many responses, including the recruitment of numerous specialized immune cells,
such as leukocytes by MIP-2(Yan et al., 1998), monocytes by MCP-1 (Deshmane et
al., 2009), and T cells, eosinophils and basophils by RANTES (Crawford et al., 2011;
Sofie et al., 2001). Furthermore, IL-6 is known to play a role in fever induction and
MMP regulation linked to IVD degeneration (Deng et al., 2016), whilst TNF-α is a
potent immunomodulator with roles in vasodilation and cell apoptosis (Pfeffer,
2003).
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Figure 3: The innate immune response leading to inflammation.
The innate immune response involves PRRs detecting either intracellular or
extracellular PAMPs or DAMPs. For example, surface PRRs, such as toll-like
receptors 2, and 4 senses DAMPs such as liberated SLRPs in the extracellular space.
Binding a DAMP to its corresponding PRR induces a signalling cascade via the
adapter molecule MyD88. This will trigger the kinase ERK, which will phosphorylate
and activate the transcription factors NF-κB and AP-1. These transcription factors
increase pro-inflammatory cytokines production including IL-6, MCP-1, MIP-2,
RANTES, and TNF-α. TNF-α is considered to be a master inflammatory regulator
whilst IL-6 has been shown to increase MMP production. MIP-2, RANTES, and MCP2 are all involved in chemotaxis and the recruitment of specialized innate immune
cells.
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1.6.4 TLR 2 and 4 ligands LPS (PAMP) and Decorin (DAMP)
Lipopolysaccharide (LPS) is the PAMP used in the present study. It is an endotoxin
commonly found as a component of the cell wall of gram-negative bacteria. LPS is a
large molecule consisting of a lipid A domain, core oligosaccharide, and an Oantigen. LPS makes up an important component of the outer membrane of gramnegative bacteria used to protect the membrane integrity from chemical influences
and help to stabilize the overall membrane structure (Zhang et al., 2013). The lipid A
component of LPS consists of a phosphorylated glucosamine disaccharide molecule
with multiple fatty acids attached to it. It is with these hydrophobic fatty acids that
the LPS molecules stays anchored to the surface membrane of bacterial cells.
Invading bacterial cells lysed by the host immune system causing the cells wall
fragments to be released into the body. Unfortunately the lipid A motif is also
responsible for the majority of LPS’s toxicity, causing fever, diarrhea, and possibly
fatal endotoxic shock commonly known as septic shock or toxic shock syndrome
(Tzeng et al., 2002). The next major component of LPS is the O-antigen made up of a
repetitive glycan polymer. It is the outermost component of the LPS molecule and is
highly variable between bacterial strains with numerous structures and
configurations (Raetz & Whitfield, 2002). Configuration of the O-antigen structures
determines its ability to protect the bacterial cell from antibiotics. Long unbranched
molecules protect the cell better than cells expressing short or reduced o-antigen
molecules (Rittig et al., 2003; Tsujimoto et al., 1999). Conversely full-length O-chains
increase surface exposure making it a good target for antibody recognition. The OMatthew Guerreiro 2018©
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antigen and Lipid A molecules are covalently bound to a core domain which
contains an oligosaccharide component that facilitates binding to the lipid A
complex. The core domain usually includes sugars and keto-deoxylctulosonate along
with non-carbohydrate components like phosphates and amino acids (Hershberger
& Binkley, 1968). In addition to being sensed by TLR 4 and trigger an innate
immune response causing the production of inflammatory chemokines, it is also a
natural pyrogen inducing fever in patients (Duff & Atkins, 1982).

Decorin is the DAMP used in the present study. It is a natural component of
the IVD extracellular matrix. In its bound form it has no apparent effects on the
immune system but once solubilized can act as a DAMP signaling a damage event to
the host cells via the PRRs, TLR 2/4 (Schaefer et al., 2005a). Averaging between 90
and 140 kDa, it is a member of the short leucine rich proteoglycan (SLRP) family.
Decorin and it structurally similar cousin, biglycan, both are made up of a protein
core containing leucine repeats and a glycosaminoglycan (GAG) chain (Babelova et
al., 2009; Gerard et al., 2003; Moreth et al., 2012). Decorin not only functions as a
DAMP when solubilized, but have been found to have far reaching roles linking the
innate and adaptive immune systems along with functions in microbial defense,
tumor suppression, muscle hypertrophy, scar suppression and reduction and
fibrillogenesis of collagen (Buraschi et al., 2013; Jumper et al., 2015; Kanzleiter et al.,
2014; Moreth et al., 2012). Release of decorin can be facilitated through physical
damage to the IVD but also a number of proteolytic enzymes such as bone
morphogenic protein (BMP)–1, matrix metalloproteinase (MMP)–1, MMP-3, and
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MMP-13, all of which can cleave the protein core solubilizing the decorin molecule
(Moreth et al., 2012).
1.6.5 Effects of Inflammation on IVD Biology
While it is widely accepted that damage to the IVD induces an inflammatory
response; the exact progression of the response and its various effects in the IVD are
not well understood. On one hand, it has been well documented that inflammation
contributes to the regeneration of the damaged IVD. This is facilitated by various
cytokines which upregulate cellular activity, promote cell proliferation and viability
and increase MMP production to breakdown damaged ECM and allow the resident
cells to lay down new ECM (Santos et al., 2013; Sun et al., 2013). On the other hand,
pro-inflammatory cytokines produced as a response to IVD damage can trigger an
exaggerated inflammatory response leading to IVD degeneration (Figure 4)
(Antoniou et al., 1996; Gabr et al., 2011; Hoyland et al., 2008; Moreth et al., 2012;
Rutges et al., 2008; Seguin et al., 2005; Smith, Nerurkar, et al., 2011; Sun et al., 2013;
Zhao et al., 2007). IL-1 has been found to be much more prevalent in IVDs
undergoing degeneration, particularly in NP region of the IVD (Hoyland et al., 2008).
Furthermore, high levels of IL-1 appear to affect cell morphology and ECM
composition, increasing the proportion of chondrocyte-like cells that are less adept
at producing new collagen fibres, and reducing the amount of aggrecan in the NP. As
previously discussed, the reduction of proteoglycans in the NP reduces the IVD’s
ability to maintain hydrostatic pressure and increases the risk of degeneration to
the IVD (Hoyland et al., 2008). Similar trends were found when the IVD was exposed
to TNF-α for prolonged periods of time. TNF-α caused down regulation of aggrecan,
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type I collagen, and type II collagen and the upregulation of IL-1 and IL-6 (Iatridis et
al., 2009).
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Figure 4. The Two Faces of Inflammation
In a controlled inflammatory response we hypothesize that inflammation will stiffen
the IVD, which will have a stabilizing effect on the IVD and promote healing.
However in many cases inflammation become exaggerated, inducing further IVD
degeneration and increased IVD laxity. This in turn will promote abnormal
movement of the IVD, inducing further IVD degeneration exacerbating a cycle of
damage.
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1.7. The Rat Tail Model
The rat-tail model has become a particularly popular method for examining
the genetic factors, altered mechanics, and effects of injury on IVD integrity (Chan et
al., 2006; Masuda et al., 2005; O’Connell et al., 2007; Sobajima et al., 2005; Zhao et
al., 2007). The rat-tail model proves to be a cost effective method for researching the
IVD, with animals reaching full skeletal maturity by about 3 months. This means the
time frame needed to propagate animals and conduct studies can be done shortly
after animals reach skeletal maturity. In contrast, other larger species, such as
bovine, while possibly having more comparable IVDs in size and morphology, also
carry significantly more costs and larger time expenditures needed to perform
comparable experiments. Relatedly, IVDs in the rat tail are easily accessible;
reducing the chance of complications or contamination when harvesting the IVDs
for tissue collection. Location of the IVD also allows treatments to be minimally
invasive and results are more reproducible compared to other models (Ching et al.,
2003; H. Zhang et al., 2011; Iatridis et al., 1999; MacLean et al., 2003). Despite these
factors, which make the rat tail model suitable for this IVD study, there are several
drawbacks that must be examined. First, there is obvious size variance between rats
and humans. The cellular composition between human and rat IVDs also shows
some variances, namely the prevalence of notochord cells in the NP. Where humans
lose the majority of their notochord-like cells by about 3 months, the NP cells of the
rat IVD maintain their notochord like morphology (Ching et al., 2003; Han et al.,
2008; Iatridis et al., 1999). Finally we must consider the way the IVD is loaded
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during daily activity between the two models. Unlike with human IVDs where we
see the majority of loading on the IVD being applied in the cranial- caudal direction
with forces being dissipated in the perpendicular plane, the rat tail undergoes
similar level loading through the tendons that run the length of the tail (Rigby et al.,
1959).

1.8 Biomechanical Properties of the IVD
The IVD undergoes complex interactions between the AF and NP allowing the IVD to
withstand dramatically variable forces, and to readily respond when loaded in 6
degrees of freedom (Palepu et al., 2012). Due to its structural complexity, the IVD
exhibits primarily anisotropic (altered mechanical properties when loaded in
different directions) properties. This is critical given that any abnormal distribution
of forces may lead to increased degeneration and reduced mobility of the joint.

1.8.1 Tension, Compression, and the Neutral Zone
Tension is defined as when a structure is pulled apart or more specifically when
forces act on the same plane of motion but in opposite directions (Haiqing & King,
1996). In the case of the IVD, the AF undergoes deformation when tensile forces are
applied allowing the IVD to maintain hydrostatic pressure in the NP and conserve
structural integrity (Griffin et al., 2016).
The converse is true of compression, where forces acting in the same plane
push the tissue together (Haiqing & King, 1996). During both standing and
movement, the IVD regularly undergoes compressive and tensile forces, which are
dispersed across the NP thanks to the hydrostatic pressure maintained within the
Matthew Guerreiro 2018©

31

IVD (Griffin et al., 2016). Amazingly, hydrostatic pressure in the IVD has been
recorded as being as much as 50% higher than the applied loads (Galante, 1967). In
both compression and tension, the IVD has a region of elasticity such that it is able
to recover from the resulting strain of an applied load without causing damage to
the tissue once the load has been removed.
The neutral zone (NZ) is the term given to define the range of motion where
the least amount of tissue resistance is experienced and is depicted as the most
horizontally linear region of a compression-tension or force-displacement curve
(Figure 5) (Smit et al., 2011). As such, it is often used as a determination of a tissue’s
range of motion and as an indication of tissue laxity or stiffness. Lower NZ slopes
suggest increased laxity while higher slopes indicate greater stiffness.
In the case of IVDs a balance must be reached between having sufficient
laxity when forces are applied to the IVD to allow for the movement, and enough
stiffness to maintain the IVDs structural integrity, particularly when compressive
forces are applied. While an increase in stiffness may be an indicator of swelling and
inflammation and promotion of a stabilizing environment for damaged IVDs,
increases in laxity in normal healthy IVDs could indicate IVD degeneration as the
IVD loses its ability to withstand the forces applied to the IVD.
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Figure 5: Representative force displacement curve
A graph depicting the sigmoidal force displacement curve, which is used to
determine the neutral zone (NZ) size and stiffness of each functional spine unit
(FSU). Here we see the amount of force (Y axis) the tissue undergoes when it is
stretched or compressed (X axis). The NZ can be viewed as the most horizontally
area of the graph where large changes in displacement have little effect on the
forces exhibited on the IVD. Outside this region, small changes in displacement
deliver large changes in force.
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1.8.3 Mechanical Properties of the Rat Tail IVD
Many studies have been done comparing the biomechanical properties
between rat and human IVDs. Upon initial examination by Elliott & Sarver (2004),
rat IVDs placed through 20 cycles of cyclic compression and tension showed
variances in NZ when compared to human IVDs. Normalizing the data to account for
size differences between the two groups indicated there were no significant
variances between compression and torsional stiffness in rat IVDs compared to
humans (Elliott & Sarver, 2004). This further supports the rat-tail model as a
suitable alternative for human IVD research despite there being differences at the
cellular level between the two species.
In two additional studies on the effects of cyclic loading, rat IVDs were found
to have stiffening analogous to that found in human degenerative IVD studies. IVDs
that were exposed to compressive loads had a 35% decrease in IVD height and
increased stiffness (Iatridis et al., 1999). Corroborating this data, rat IVDs that
underwent prolonged cyclic compressive loading over a two-week period
experienced increasing levels of stiffness as time progressed (Ching et al., 2003).

1.8.4 Effects of Inflammation on IVD Biomechanics
As previously discussed the exact role of inflammation on the IVD is mostly
uncharacterized, indeed, the exact role the inflammatory response plays in IVD
repair, IVD degeneration and general IVD mechanics has yet to be fully
charecterized.
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TNF-α, being one of the master regulatory factors in innate immunity, makes
it a prime target cytokine for immunity studies and potential downstream
neutralization to reduce the degenerative effects of inflammation. Along with being
known to influence IVD matrix degradation (Hoyland et al., 2008; Seguin et al.,
2005), TNF-α has also been shown to trigger Wnt-β-catenin signaling pathways to
inhibit NP cell growth and proliferation (Hiyama et al., 2013).
One study found explored the effects of TNF-α on IVD mechanical properties.
Regrettably this study was conducted in bovine IVDs and thus any results would
need to be further validated to determine their comparability to rat and human
studies, however as one of the only studies investigating inflammation and its
effects on IVD biomechanics it is a significant piece of literature. The study reported
that the type of loading the IVD was exposed to affected TNF-α’s ability to penetrate
the IVD. TNF-α treated IVDs under dynamic loading saw TNF-α penetration of the
IVD in as little as 8 hours whilst IVDs that underwent static loading showed no TNFα penetration during the 24 hour test period. Interestingly TNF-α expression was
highest in the NP of IVDs that were subjected to dynamic loading with an average
increase of 38%, though TNF-α levels in the AF, and vertebral endplates were not
significantly different from controls. Presence of inflammatory cytokines in the IVD
was also reported to have severe implications on IVD integrity and in all cases
reduced IVD compliance. Also, histological analysis showed increased collagen
production in the AF of TNF-α exposed IVDs along with reduced levels of aggrecan
in the NP of the same IVDs (Walter et al., 2015). As aggrecan is one of the core
proteoglycans of the NP ECM required to maintain hydrostatic integrity of the IVD, it
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is not surprising that IVDs that experienced loss of proteoglycans also had severely
compromised structural integrity.

1.9 Project Aims
This project aims to analyze the effects on an innate inflammatory response on
resident IVD cells comparable to what would be seen during herniation or similar
IVD damage, then determine if that inflammatory response had any effects on the
biomechanical properties of the IVD at the tissue level.
My project can be subdivided into five parts in order to answer my thesis
question; the first part was to isolate cells from the AF and NP of Sprague Dawley rat
(Rattus norvegicus) IVDs harvested from the tail and grow them in culture; secondly,
I confirmed the identity of the cultured AF and NP cells using RT-PCR; thirdly I
determined the basal expression levels of each type of innate PRR for both cell
types; fourthly I challenged the AF and NP cells with danger- and pathogenassociated molecular patterns (DAMPs, PAMPs) and determined the inflammatory
response by measuring changes in cytokine production using a multiplex array.
Finally, I treated functional spine units (FSU) with an inflammatory stimulus and
measure the changes in the biomechanical properties of the IVD compared to
untreated controls.
I hypothesized that cells challenged with an inflammatory stimulus will
initiate an inflammatory state by increasing inflammatory cytokine production. This
inflammatory response will lead to swelling on the IVD and lead to an overall
stiffening effect on the joint.
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Chapter 2. Materials and Methods
2.3.1. Cell Culture
The isolation protocol for AF and NP cells was adapted from cell culture
methods described previously (Gruber et al., 2002; Hiyama et al., 2013; Kong et al.,
2014). Young animals were used for IVD collection as rats aged 2-3 months yield
IVD tissue with successful long-term annulus cultures 60% of the time. Older
animals (8-10 months) yield successful long-term cultures only ~20% of the time
(Gruber & Hanley, 2014). Seven rats were used for AF and NP cell culturing. AF and
NP tissues were collected from the intervertebral IVDs of the tails of freshly
sacrificed male Sprague Dawley rats, Rattus Norvegicus, under aseptic conditions. All
AF tissues from a single animal were pooled, as were the NP tissues. Tissues were
washed 3 times in Dulbecco phosphate buffered saline (DPBS) modified without
calcium or magnesium (SH30028.02, HyClone, South Logan, UT, USA) with 2%
penicillin-streptomycin stock (Stock concentration; 200 μl/mL penicillin, 200
units/mL streptomycin, Fisher, Fairlawn, NJ, USA).
2.3.2. AF Cells
AF tissues were blunt dissected, using forceps, into 1mm2 pieces, then plated
in 100mm cell culture petri dish with DMEM modified with sodium pyruvate, and
4.5 GM/L glucose (Bioshop, Burlington, Ont, Canada), 10% fetal bovine serum (FBS,
Sigma-Aldrich, St. Louis, MO, USA), 100 μl/mL penicillin – 100IU/ mL streptomycin
(1% Pen-Strep, Fischer, Fairlawn, NJ, USA), and 25mM of HEPES free acid (Amresco,
Solon, OH, USA).
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Tissues were initially cultured in 2mL of media until pieces of tissue had adhered to
the petri dish, then the media volume was gradually increased to 10mL with 50% of
media being changed 3 times/ week until tissue explant growth had occurred and
cells had reached confluence. Cells were incubated at 37oC with 5% supplemental
CO2 throughout the culturing process. Once cells has reached confluence, they were
subcultured 1:2 in vented T75 flasks, after cells had been washed 2 times with DPBS
with 2% Pen-Strep then lifted with 2mL of 0.25% trypsin/ 0.53mM EDTA (30-2101,
ATCC, Manassas, VA, USA).
2.3.3. NP Cells
NP tissues were broken up by vigorously pipetting then plated in poly-Llysine coated T75 vented flasks with RPMI-1640 (30-2001, ATCC, Manassas, VA,
USA) supplemented with 10% FBS, 1% pen-strep and 25mM HEPES. NP cells were
incubated and subcultured as previously described in 2.3.2.
2.3.4. NR8383 – Rat Lung Macrophage Cells
NR8383 cells were purchased from ATCC (CRL-2192, Cedarlane labs,
Burlington, Ont, Canada) and plated at 4x105 cells/mL in T75 vented flasks as per
manufacturer’s instructions in Ham’s F12K media with 15% FBS and 1% pen-strep.
Cells were incubated at 37oC with 5% supplemental CO2 throughout the culturing
process and subcultured 1:2 by detaching the cells using a cell scraper. As with the
other cell types 50% of the media was changed 3 times per week to maximize cell
growth.
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2.3.5 RT-PCR
AF, NP and NR8383 RNA were collected from cell cultures using Sigma’s
GeneElute Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, St Louis, Missouri,
USA, Catalogue #RTN70-1KT) following manufacturer’s instructions (Appendix B).
All 3-cell types were run against the primers listed in Table 1 to generate PRR
expression profiles using the NR8383 cells as positive controls for all primers.
Primers were purchased from Sigma-Aldrich (St. Louis, MO, USA). Annealing
temperature for each primer pair was optimized in a previous PCR reaction, and
then the optimum temperature was used in this final set of RT-PCR reactions. The
control lane is an RT-PCR reaction using the GAPDH primers but substituting cDNA
for DNA quality water to ensure no contaminants are present.

RT-PCR products

were ran on a 1% agarose gel stained with 0.5 μg/mL EtBr. Images taken on a
VersaDoc 4000 with UV trans illuminator, 1.4 F-stop fixed lens and 5-second
exposure.

The identity of each RT-PCR product was validated via sequencing

(Laboratory Services Division, University of Guelph, Guelph, Ont, Canada).
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Table 1. RT-PCR Primers
Complete list of primers used to identify PRRs expression in the AF and NP cell
cultures using RT-PCR. Also listed are primer used to verify cell identity as AF or NP.
Included are the forward and reverse primer sequences, the expected product size
of each PCR product, and the cognate ligand for each receptor.

Target

Associated Ligands

Forward Primer

Reverse Primer

Product
Size

Annealing
Temp

TLR1

5'-GCTATGGCAGTGGACACAGA-3'

5'-CCAGAACTCCCCAGTGTTGTT-3'

601

55 C

TLR2

Short Leucine Rich
Proteoglycans
(SLRPs)

5’-ATGAGTCCCGAAGTCTACAGTCA-3’

5’-GCTCCGTATTGTTACCGTTTCTAC-3’

383

50 C

TLR3

dsRNA

5ʹ-GATTGGCAAGTTATTCGTC-3ʹ

5ʹ-GCGGAGGCTGTTGTAGG-3ʹ

205

50 C

TLR4

Short Leucine Rich
Proteoglycans
(SLRPs)/LPS

5’-CGCTCTGGCATCATCTTCAT-3’

5’-CTCCTCAGGTCAAAGTTGTTGC-3’

232

55 C

TLR5

Host RNA

5ʹ-GAATCCGGAACCTAGCGCAT-3ʹ

5ʹ-GCACCCTGTTGACACGAAAA-3ʹ

664

50 C

TLR6

Bacterial
Lipoproteins

5ʹ-GGGGCTTTCCTCTGTCTCTA-3ʹ

5ʹ-CCCAAGTTTCAAGTTTTCACAT-3ʹ

593

55 C

TLR7

o
o
o

o

o
o
o

5ʹ-GTCACCTCTATTTCTGGGATGT-3ʹ

5ʹ-AATCACATCAACTTTTTCATCC-3ʹ

379

50 C

TLR8

Host RNA
Host RNA

5'-CGGAAAGGGGAAAACATGTCC-3'

5'-TTTGGGTGCTGTTGTTTGGC-3'

317

50 C

TLR9

Host DNA

5’-CATCATGGTTCTCTGTAGCAGG-3’

5’-AGCAGTTCCCGTCCATGAAG-3’

539

50 C

TLR10

Unknown

5ʹ-TTTTCCAGAGCTGCCAGGAG-3ʹ

5ʹ-GGGTCAAAGTTCCTCTCGGG-3ʹ

502

55 C

5'-TGACTGCTTCCGTTGGTGTT-3'

5'-CAAAGCCTTCAAACCTCCGC-3'

558

50 C

5'-AGCACAGACTTGGATAACGCA-3'

5'-TGCACACCATCATCTTCCCC-3'

689

50 C

5'-TGCATGCCGTATCTGGTTGT-3'

5'-TGCATCATTCCACTCTGGCT-3'

686

55 C

5'-CCCAGAGTCAACCACCACTG-3'

5'-CTCCATTGCTTTCTGGCCTCA-3'

415

50 C

5'-GGTGTTTTCCAGGCTGATCC-3'

5'-AGGTGGCAGAAGCAACAGAA-3'

390

55 C

RIG-I
MDA5
NLRP3
DAI
AIM2

Host RNA
Short Leucine Rich
Proteoglycans
(SLRPs)
Host DNA

o
o
o
o
o

o

o
o
o

MINCLE

Host Proteins

5'-TGCATCACACCACACAGAGAG-3'

5'-GATAACCACCAGGTGAGCCC-3'

337

55 C

DECTIN

Necrotic Cells

5'-AGGCATCCCAAACTACAGGC-3'

5'-TGACTTGAAACGAGTTGGGGG-3'

300

55 C

GAPDH

None

5'-GCATCTTCTTGTGCAGTGCC-3'

5'-ACTGTGGTCATGAGCCCTTC-3'

567

55 C

COMP

None

5'-CCACTGCCTGCGTTCTAGT-3'

5'-AAGCATCTGTGGGGCTAGGT-3'

95

55 C

GLY3

None

5'-GCCCTGAACCTCGGAATTGA-3'

5'-AGCAGTACCACATTCGGGTG-3'

94

55 C

K19

None

5'-TGATGAGACGTTGAACACCCA-3'

5'-CGAGTTCCGTGACCTCAGTC-3'

97

55 C
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2.3.6. Multiplex Assay
AF cells (passage <4) were plated in 12 well plates and were allowed to grow
in a monolayer in regular growth media previously described. NP cells (passage <4)
were similarly plated in poly-L-lysine coated 12 well plates. Wells were treated with
media alone or with 10 μg/mL LPS (Sigma-Aldrich, Oakville, Ont, Canada), or 5
μg/mL bovine decorin (Sigma-Aldrich, Oakville, Ont, Canada, Cat#D8428), for each
time point or 2, 6, 12, 18, 22 and 24 hours. Concentration of LPS and Decorin were
chosen based on previous studies (Schaefer et al., 2005b) with concentrations
chosen that induced noticeable changes in inflammatory cytokine production. Cells
were exposed to serum free conditions for the initial 2 hours then media was
changed to normal growth media for each cell type with the above-mentioned
agonist concentrations for the duration of the experiment. Serum free media was
initially used as FBS was seen to have a protective effect on the cells delaying
inflammatory cytokine production. All media was collected, centrifuged at 15.0x G
for 15 minutes before being aliquoted into 60 μl aliquots and stored at -80 oC until
multiplex assays were performed.
Multiplex reagent kits were purchased from Bio-Rad (Bio-Rad, Mississauga, Ont,
Canada) along with Rat standards and cytokine for TNF-α, MIP-2, RANTES, IL-6, and
MCP-1. Multiplex assays were performed according to manufacturer’s instructions
using a Bio-Plex MAGPIX Multiplex Reader (Bio-Rad, Mississauga, Ont, Canada).
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2.3.7 Biomechanical Testing
19 male Sprague Dawley rats, averaging 1 year old and 550g-650g, (rattus
norvegicus) were obtained from the Wilfrid Laurier University Animal Care Center
(Waterloo, Ont, Canada), which were being kept under other faculty member’s
existing approved animal utilization protocols. Freshly sacrificed animals were
dissected and 3 FSUs were collected from each animal tail. FSUs were randomly
assigned to the test conditions outlined in Table 2. FSUs exposed to decorin were
injected with 20ul of PBS solution with the prescribed dissolved decorin
concentrations (0.5 or 5 μg/mL) whilst PBS only samples were injected with 20uL of
PBS (Figure 6). Injections were carried out using a 33 gauge needle, placed in 2mLs
of normal DMEM growth media and incubated at 37 oC. Following incubation of 24
hours or 6 days, FSUs were mechanically tested using a uniaxial material testing
system (UStretch, CellScale Biomaterials Testing, Waterloo, Ont, Canada) (Figure 7).
FSUs were subjected to 10 cycles of cyclic compression and tension to precondition
the IVD and determine the loading limits of the IVD. IVDs were further subjected to
an additional 15 cycles of compression and tension using the last cycle to generate a
force displacement curve (Figure 5). Biomechanical data was collected and analyzed
using MatLab software to graph the force-displacement curve for each FSU and to
determine the NZ size and stiffness.
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Table 2. Experimental Conditions for Biomechanical Testing
A table illustrating the experimental conditions and how each FSU was divided
between the 9 test conditions. 3 FSUs were harvested from each rat with each FSU
randomly assigned to 1 of the 3 treatment groups.
Test Condition
1 Day Incubation
(N=8)
6 Days Incubation
(N=8)

Treatment 1
5 μg/mL
Decorin
5 μg/mL
Decorin
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Treatment 2
0.5 μg/mL
Decorin
0.5 μg/mL
Decorin

Treatment 3
PBS
PBS
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Figure 6: FSU Harvesting and Experimental Setup
A diagram depicting the 3 FSUs being harvested which were randomly assigned to
the 3 experimental groups; untreated control, sham (PBS) injection, 20 uL injection
of 0.5 μg/mL decorin solution, or 20 uL injection of 5.0 μg/mL decorin solution.
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FSU

Figure 7: UStretch used for compression-tension testing
Image depicting the UStretch (Cellscale, Waterloo, Ont, Canada) used for
compression-tension testing of all FSUs from each of the test conditions (0.5 μg/mL
Decorin in PBS; 5 μg/mL Decorin in PBS; PBS only)
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2.3.8 Statistics
Statistical analysis of multiplex data (cytokine and chemokine raw concentration
values) was performed using SAS V9.2 (SAS Institute Inc., Toronto, Ont., Canada) via
a two-way ANOVA with the factors “condition” (three levels: control, LPS, decorin)
and “time point” (six levels: 2, 6, 12, 18, 22, 24hrs). Tukey’s post-hoc tests were
conducted to determine significant changes in cytokine/chemokine concentrations
for each condition and time point as well as on fold changes in LPS and decorin
cytokine/chemokine concentrations relative to control at each individual time point.
A second two-way ANOVA was conducted on the NZ size and stiffness data with the
factors “incubation period” (two levels: 24 hrs and 6 days) and “condition” (three
levels: 0.5 μg/mL decorin, 5.0 μg/mL decorin, PBS control). P<0.05 was considered
to be significant.

Chapter 3. Results
2.4.1 Cell Culture
Over the course of this experiment, AF and NP tissues were successfully
isolated and primary cell cultures were established (Figure 8). AF cells were visibly
sandwiched as round cells between layers of collagen fibers. In addition to being
larger than their NP counterparts, AF cells appeared to have a fibroblastic
morphology in culture. Five days post-culture, the first AF cells were visible
migrating away from the explant tissues. Cell populations quickly expanded such
that within 10 days post-culturing the AF cells had reached confluence in T75 flasks.
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NP cells similarly had a round morphology upon initial culturing. Cells could be seen
attached to the poly – L – lysine coated flasks within 24 hours of culturing. Despite
this, it took 10 days for cells to take on their final morphology and begin visible
growth. Cells took an additional 5-10 days to reach confluence in a T75.
Cell identity and purity of primary cell cultures was confirmed using RT-PCR. AF
cells showed high expression of cartilage oligomeric matrix protein (COMP) but no
expression of glypican 3 (GLY3) or cytokeratin 19 (K19). Conversely, NP cells
showed no expression of COMP, though GLY3 and K19 were both present. As
expected both the AF and NP cells show strong expression of our control gene,
GAPDH (Figure 9).
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0 Days

First Cells Attach

10 Days

15 Days

NP

AF

Figure 8: Culturing AF and NP Cells
Images depicting the growth of cultured AF and NP cells. Both cell types initially
have a rounded morphology with NP cells being free floating and AF cells being
trapped between collagen fibres. Once cells attach or being to explant their
morphology changes. AF cells were noted to reach confluence around day 15 post
culture whilst NP cells took an additional 10 days.

Matthew Guerreiro 2018©

48

Figure 9: Confirmation of AF and NP cell identity
RT-PCR results of cartilage oligomeric matrix protein (COMP), glypican 3 (Gly3),
cytokeratin 19 (K19) transcript expression in AF and NP cells, using GAPDH as a
housekeeping control gene. AF cells expressed COMP and GAPDH whilst, Gly3, K19
and GAPDH were all expressed by NP cells. Differential expression by our two
primary cell cultures allowed for verification of cell identity between the different
cell populations.
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2.4.2 PRR Expression Profiles
PRR expression profiles were generated using NR8383 cells as positive
controls. NR8383 cells expressed a wide range of receptors showing positive
expression for all PRRs tested along with our control gene, GAPDH (Figure 10). AF
and NP cells showed varied expression between the two cell types. AF cells showed
strong expression of TLR 2, 3, 4, and 6 as well as RIG-I. Expression of TLR 1, 7, 8, and
9, MDA5, Mincle, and Dectin were also present though at much weaker levels
(Figure 11 – AF). NP cells showed much stronger expression of TLR 1, 2, 3, 4, 6, and
Dectin, though TLR 5, 8, 9; RIG-I and AIM2 were also present (Figure 11 – NP). PRR
expression profiles were also noted to be consistent between primary cell cultures
obtained from non-familial animals where PRR profiles generated from 3
individuals from different litters were all found to have the same PRR profiles.
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Figure 10: NR8383 PRR expression profile
Expression profile of PRRs expressed rat lung macrophage cell line as detected by
RT-PCR, using primers from Table 1. GAPDH was used as a positive control. Each set
of primers yielded products of the correct size, which were subsequently verified
via sequencing.
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Figure 11: AF and NP PRR Expression Profiles
Representative expression profiles of PRRs at the transcript level in AF cell cultures
(AF) and NP cell cultures (NP) using RT-PCR (N=3).
Each primer annealing temperature was optimized in previous PCR reactions then
the optimum temperature was used in this final set of RT-PCR reactions. The control
used GAPDH primer but substituted cDNA for DNA quality water to ensure there
were no contaminates to the PCR mixtures.
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2.4.3 Cytokine Expression
As TLR2 and TLR4 were visibly expressed in both cell types, a PAMP and
DAMP for these receptors, LPS and decorin respectively, were selected for use in
challenge studies. AF cells challenged with LPS showed early peak expression of
MCP-2 and MIP-2, with expression peaking at 57.68 and 38.35 fold greater than
untreated controls respectively, (6 hours post exposure) before expression levels
began returning to normal levels. Expression was not found to be statistically
different between 6 hours and 24 hours post treatment. Production of IL-6 and
RANTES were found to peak at 18 hours (137.93 and 161.08 times greater than
controls) with expression quickly dropping by 22 hours (Figure 12a). Production of
RANTES was not statistically different between 12 hour and 18 hour time points
whilst IL-6 was not statistically variable between 18 and 22 hours, though was
found to have significant variance between 12 and 18 hour time points. In NP cells,
IL-6 followed a similar trend, though in much greater concentrations, to that of AF
cells treated with LPS. Peak levels of the cytokine were 385.57 times greater at 18
hours then controls. RANTES and MIP-2 showed delayed increases in cytokine
production, not peaking until 22 hours (74.87 and 61.6 fold increase; 18, 22, and 24
hour time points were not significantly different from each other for RANTES; 12,
18, 22, and 24 hour time points were not significantly different from each other for
MIP-2) and had not shown significant reduction in cytokine production at the
conclusion of the experiment (Figure 12b). In contrast to what was seen with AF
cells, NP cells showed no significant changes in MCP-1 expression compared to
control levels at any point during the time course (Figure 12). AF cells challenged
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with decorin showed similar expression profiles to that of their LPS challenged
counterparts. Expression levels were noted to be lower in all cases when cells were
challenged with decorin compared to cells challenged with LPS (IL-6 = 95.91, MCP-1
= 43.37, RANTES = 98.62, MIP-2 = 30.67). MCP-1 and MIP-2 both peaked earliest
whilst RANTES again peaked at 18 hours. IL-6 expression also showed a delayed
response when challenged with decorin, and did not peak until 22 hours (Figure
13a). Surprisingly NP cells treated with decorin did not show the same expression
profiles to LPS treated cells, loosing expression of RANTES in addition to MCP-1
(Figure 13b). IL-6 however, did peak at 18 hours again as was observed when NP
cell were treated with LPS but the PAMP induced a 4 times stronger reaction than
the decorin treated cells. MIP-2 was also noted to peak earlier than LPS treated cells
at 12 hours (62.34 fold great than controls). Neither cells treated with LPS or
decorin showed increases in TNF- α production from control values.
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Figure 12: Cytokine Expression Following LPS Stimulation in AF and NP Cells
Figure 12: Multiplex data over a 24-hour time course showing the fold change in IL6, MCP-1, RANTES, and MIP-2 expression in AF cells (A) and NP cells (B) treated
with 10 μg/mL LPS relative to control. N=3. Asterisks indicate significant fold
change from control at each individual time point. Statistics reported are based on
raw data values (* p<0.05, **p<0.005, ***p<0.0005, ****p<0.00005).
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Figure 13: Cytokine Expression Following Decorin Stimulation in AF and NP Cells
Multiplex data over a 24-hour time course showing the fold change in IL-6, MCP-1,
RANTES, and MIP-2 expressions in AF cells (A) and NP cells (B) treated with 5
μg/mL Decorin relative to control. N=3. Asterisks indicate significant fold change
from control at each individual time point. Statistics reported are based on raw data
values (* p<0.05, **p<0.005, ***p<0.0005, ****p<0.00005).
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2.4.4 Effects of Incubation Time and Inflammation on IVD Biomechanical Properties
NZ size was not affected by either the length of incubation (24 hours versus 6
days; p=0.1612) nor by the addition of decorin (p=0.3727). However collapsed
across condition (0.55 μg/mL decorin, 5.0 μg/mL decorin, and PBS), NZ stiffness
was lower after 6 days of culture when compared to 24 hours (p=0.0377).
Moreover, a significant interaction between incubation time and the addition of
decorin was observed for NZ stiffness (p=0.0329). This interaction was such that
decorin, regardless of concentration, 0.5 μg/mL or 5.0 μg/mL, had no significant
effect on IVD NZ stiffness (p=0.40) following 24 hours of incubation (Figure 14)
when compared to the PBS control samples but did have an effect after 6 days of
incubation. Specifically, increased NZ compliance was observed in 5.0 μg/mL
decorin samples compared to PBS control samples (p=0.016) and close to significant
increased compliance in the 0.5 μg/mL decorin samples (p=0.09).
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Figure 14: Neutral Zone Stiffness Over Time
Graph depicting significant interaction between incubation time (24 hours versus 6
days) and condition (PBS, 0.5 μg/mL decorin, and 0.5 μg/mL decorin) for NZ
stiffness (p=0.0329). NZ stiffness did not differ between conditions after 24 hours
incubation (p=0.40); however by 6 days, decorin injected samples showed increased
laxity (p=0.09 and p=0.016, for 0.5 ug/mL and 5 μg/mL decorin injected IVDs
respectively) when compared to the sham IVDs at 6 days, as indicated by the
asterisk. Further, the NZ stiffness for the sham IVDs did not change from 24 hours to
6 days.
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Chapter 4. Discussion
The current study utilized a multi-disciplinary, integrative, and novel approach to
investigating inflammation in the IVD. Through this work a collaborative approach
was undertaken, with work being conducted in both the DeWitte-Orr lab and the
Gregory lab, but also by integrating the fields of biomechanics, immunology and
cellular biology. This has allowed us to compare changed observed at the cellular
level to functional changes at the tissue level.
A number of key findings were observed: first, it was found that both a PAMP
(LPS) and a DAMP (decorin) resulted in a significant increase in pro-inflammatory
chemokine and cytokine production in cultured AF and NP cells. While this was
anticipated as it was also found that both IVD cell types have TLR2 and TLR4
receptors on which LPS and decorin bind, such extensive PRR profiles and
progression of cytokine production have never been reported previously in the
literature. Second, intact IVDs, when injected with decorin, became significantly
more compliant after 6 days of culture, compared to control IVDs, indicating a
potentially negative effect of inflammation on IVD joint mechanical integrity. This
increased laxity could have detrimental effects if the IVD is exposed to a longterm
inflammatory environment.

4.1 Culturing AF and NP Cells and the Identification of PRRs
The present study shows that the resident cells of the AF and NP can be
successfully grown in culture from tissues. At present, cells were successfully
cultured from tissues harvested from the IVDs of rat-tails (Figure 8). In each case,
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cells had the expected morphology and cellular markers previously described in the
literature. In contrast, growth conditions required to sustain NP cell growth had
several variations to what had been previously described, namely changing the
growth media from DMEM to RPMI and the use of poly-L-lysine coated culture
flasks. These changes were made to enhance cell viability as we observed culturing
NP cells in DMEM caused osmotic variation leading to cell bloating in most, and
eventually death. Furthermore, using proteases to breakdown of the NP ECM using
the isolation process, identified in the literature (Lee et al., 2015), was also
discontinued as this caused similar cellular bloating and death observed when using
DMEM. Also, NP cells were highly susceptible to shearing forces, particularly in the
initial passages. Additionally, establishing successful primary cell cultures was also
dependent on the age of the animal from which the tissues were harvested. Animals
between 3 and 6 months had the most success when establishing cultures and also
had the most rapid growth of NP cells. AF cells in contrast appeared to be much
more robust and grew remarkably well under established conditions. AF cells
collected from both young and old animals could be successfully explanted within
the time frames established in figure 8.
Additionally, the cell identity of each primary culture was confirmed based
on the unique cellular makers expressed by each cell type. The protein COMP was
found to be uniquely expressed by AF cells but not by NP cells whilst. Conversely,
GLY3 and K19 is predominantly produced by NP cells when compared to rat AF
tissue and articular cartilage ( Lee et al., 2007).
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From those pure cell cultures we have determined the PRR profiles for each of our
cell types and have identified PRRs common to both AF and NP cells, which were
chosen for challenge studies. PRR expression was measured at the transcript level
using RT-PCR and it was determined that AF and NP cells expressed different PRR
profiles (Figure 11). While the variation in PRR profiles was expected, the exact list
of receptors expressed by each cell should help fill a critical gap in the literature and
as such help determine future possible areas of study for IVD related inflammation.
The fact that TLRs 2 and 4 were both expressed by the AF and NPs became a
particularly interesting avenue to explore as these PRRs suited many of our criteria
making them excellent potential targets for this experiment. Some of these criteria
included the PRRs having well characterized inflammatory pathways with known
cytokine production giving us viable targets to characterize for inflammatory
profiles using the multiplex array. The PRRs having known DAMP and PAMP stimuli
was also an asset as it allowed us to compare and contrast inflammatory responses
with different origins Furthermore, being expressed on the surface of the cell
removed the need to internalize are stimuli of choice and any neutralizing antibody
which may be used in future studies for blocking assays.

4.2 Challenging AF and NP cells with DAMP/PAMP
AF and NP cells were then exposed to a DAMP, (decorin), and the PAMP,
(LPS), to determine the inflammatory profiles of 5 chosen pro-inflammatory
cytokines over a 24-hour time course. Cytokines were chosen based on several
factors. Previous literature where TNF-α was used to determine the effects of
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inflammation on IVDs (Walter et al., 2015) and the fact TNF-α is considered a
master regulator of innate immunity contributing to vasodilation related immune
cell recruitment made it an excellent candidate for this study. IL-6 has similarly
been characterized in the literature to play a role in IVD degeneration via MMP
mediated ECM degradation (Burke et al., 2002; Deng et al., 2016). The
immunoprivileged nature of the IVD also means that it will require the help of
external immune cells. We hypothesized resident cells of the IVD will take on the
role as sentinels for damage and infection then recruit specialized innate immune
cells. Three chemokines; MIP-2, RANTES, and MCP-1, were thus also chosen as
cytokine candidates as together these three chemokines are capable of recruiting a
wide variety of specialized innate immune cells.
Progression of the inflammatory response for each cytokine based location
within the IVD allows us to build an idea of what cells are bing signaled for the
different DAMP/PAMP response (Table 3). LPS induced inflammation in AF cells
showed early peak expression of MCP-1 and MIP-2, which was, sustained though the
24 hour time course. This suggests early recruitment of macrophages and
leukocytes. This response is similar to what could be expected in a bacterial
infection where a strong immediate immune response, capable of clearing invading
pathogens and not ceasing until the infection has been removed, is preferable. Late
stage IL-6 production may support this hypothesis given the pathogen could not be
removed and the next phase of inflammation is starting (initiation of fever inducing
cytokines). Similar supporting evidence can be seen in the AF and NP data when
cells were treated with damage associated ligands. The generally lower levels of
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cytokine production would produce a weaker immune response, and may be the
IVDs method to creating a more balanced inflammatory response that will promote
healing. The NP cells inability to produce MCP-1 and thus recruit monocytes may
also be a factor of geography. As the most internal region of the IVD it may be
preferential to have the AF and VEP act as sentinels for damage and infection. Being
more closely located to tissues and blood vessels where macrophages reside the AF
will be far more efficient at recruiting them when a PAMP or DAMP is sensed. Once
inflammation was confirmed in both cell types the scope of the experiment was
increased to establish if the inflammatory response presented by the cells had any
effect on the biomechanical properties of the IVD when a decorin-induced
inflammatory response was initiated.
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Table 3: Summary of Cytokines and their Possible Biological Effects
A summary of the production of each cytokine the possible effect of resulting from
cytokine production and its proposed implications in the context of the immune
response.
IL-6
MCP-1
RANTES
MIP-2
Induces fever,
Recruitment of
Recruitments of
Recruitment of
Role
increases MMP
production
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4.3 The Effect of Induced Inflammation on IVD Biomechanics
This study examined the role of inflammation on IVD biomechanics by
separating the physical damage to the IVD from the inflammatory response by
injecting the IVDs directly with the DAMP, decorin. Specifically a small gauge needle
was used to minimize damage to the IVD in order to isolate any changes caused by
the addition of decorin rather than damage. In this study, an inflammatory response
was induced in the IVD when injected with decorin. This led to increased laxity
(Figure14) 6 days post -injection, particularly with the higher concentration of
decorin (5 μg/mL), potentially as a result of ECM degradation. When an
inflammatory response is controlled, inflammation may aid in IVD regeneration and
repair by improving cell viability and increasing extracellular matrix production and
rearrangement to promote healing (Rastogi et al., 2013; Santos et al., 2013; Sun et
al., 2013). However the inflammatory process can easily become unbalanced.
Increases in IL-6 and MMP production have been shown to alter the ECM
composition (Deng et al., 2016). A heightened inflammatory response in concert
with the avascular nature of the IVD would lead to increased ECM breakdown along
with less nutrients, oxygen availability, and clearance of cellular waste. Instead of
repair to the IVD via MMP mediated ECM restructuring, the lack of resources
delivered to the IVD would fail to meet the increased cellular demands needed for
increased cell growth and the laying of new ECM. This would cause further
degeneration of the IVD and increased IVD laxity as a result. Interestingly, increased
laxity following exposure to innate cytokines is contrary to what has been
previously noted in the literature. Specifically, bovine IVDs challenged with TNF- α
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resulted in a stiffening effect (Walter et al., 2015) rather than increased compliance.
This could be due to several factors that include a variation in IVD responses
between rat and bovine IVDs, or in the manner in which the IVD ECM is affected.
Walter et al. specifically noted the increase in collagen production and the reduction
in aggrecan in the NP. Since there was no significant change in TNF-α production
during the decorin or LPS induced inflammatory response, it stands to reason that
the lack of TNF-α and upregulation of other inflammatory cytokines caused a
different response in the IVD that that seen by Walter et al. leading to increased
laxity. This is possible because the lack of TNF-α production may not have increased
collagen production in our model as was seen in the bovine IVDs. Instead,
degradation of collagen fibers and other ECM components caused by increased MMP
due to higher levels of IL-6 activity could account for the increased laxity observed
in our study. To confirm this hypothesis histology would be needed showing
changes of collagen concentrations in decorin treated rat IVDs.

Future Directions
Further experimentation to determine if the identified inflammatory
response can be mitigated is still needed; however, we hypothesize the following
based on our results. Native molecules in the ECM of the IVD, such as decorin, would
become solubilized during IVD herniation. These DAMPs are sensed by resident AF
and NP cells via their PRRs, such as TLR2 and 4 (Figure 15-1), which in turn would
produce pro-inflammatory cytokines and chemokines (Figure 15-2). Macrophages
in the tissues surrounding the IVD and neighbouring blood vessels would follow the
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chemokine gradient to the site of herniation (Figure 15-3). Once at the site of
herniation, the macrophages would begin to produce different cytokines (IL-1β and
TNF-α) at high levels to aid on IVD remodeling and repair (Figure 15-4). Conversely,
these cytokines would also induce resident AF cells to secrete proteases that cause
ECM degradation, which over time would lead to IVD laxity and degeneration
(Rastogi et al., 2013). It has been shown that AF-secreted proteases break down
proteoglycans like decorin (Rutges et al., 2008), which would result in a reduced
ability for the NP to retain water and an increased activation of resident cells and
recruited macrophages by their TLR 2 and 4 pathways, producing more cytokines
and a positive feedback loop. These two effects in turn could alter the hydrostatic
equilibrium and mechanical integrity of the IVD, leading to direct effects on the
IVD’s biomechanics (Han et al., 2008; Issy et al., 2013; Michalek et al., 2010). Loss of
hydrostatic pressure in the NP would reduce the IVD’s ability to displace
compressive forces, which would be exerted along the rest of the spine as a
consequence. Protease-mediated structural changes in the AF would further reduce
the IVD’s ability to withstand compressive forces during movement. This could in
turn cause further fissures within the IVD increasing the probability for new
herniations to occur (Inoue & Espinoza Orias, 2011; Gregory et al., 2012; Michalek et
al., 2010).
As several treatments have been developed to target and suppress the
activity of IL-6 and TNF-α, all of which are meeting variable clinical success (Molinos
et al., 2015), this further highlights the complexity of the innate immune system and
its role in LBP. Currently, studies using neutralizing drugs to target TNF- α or IL-6
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have shown mixed results in clinical trials (Risbud & Shapiro, 2014; Molinos et al.,
2015). These results may be explained by the fact that inflammation is affected by
the cumulative actions of multiple cytokines working in cohort. Therefore targeting
any individual cytokine will have limited results. Instead blocking of the PRR
pathway with neutralizing antibodies or inhibitors would block inflammation
upstream of cytokine production mediating all inflammatory cytokines produced as
a consequence of PRR activation, instead of just a single end product. This could, in
turn, increase the efficiency of reducing inflammation and preventing further IVD
degeneration following herniation. Based on this work I hope that further research
will be undertaken to investigate the effectiveness of treatment protocols that target
upstream receptors to help alleviate the inflammatory response before it reaches
the degenerative stage currently being seen in IVDs (Figure 16). We believe that
targeting upstream PRRs that initiate the inflammatory response could prove to be a
highly effect treatment strategy.
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Figure 15: Proposed progression of a decorin mediated inflammatory response
(1) Herniation occurs causing bound decorin in the extracellular matrix of IVDs to
become solubilized. Solubilized decorin binds to surface PRRs such as TLR 2 and 4
of resident AF and NP cells within the IVD. (2) PRR activation causes a signal
cascade (Figure 3) resulting in the release of pro-inflammatory cytokines and
chemokines. (3) These released chemokines form a concentration gradient
recruiting specialized innate immune cells like macrophages from the surrounding
tissue and blood vessels to the site of herniation. (4) The macrophages begin
releasing their own cytokines such as TNF- α promoting further inflammation and
activating an adaptive immune response. This culminates to pain and further IVD
degeneration.
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Figure 16: Proposed Model for Limiting Inflammatory Progression
We hypothesis that using a neutralizing antibody that targets PRRs and blocks them
from initiating an inflammatory response we will be able to reduce inflammation
and in turn the degradative effects seen within IVDs. We hope that this will provide
a novel avenue for future therapeutics.
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Summary
1. The main subject: LBP and innate immunity
a. LBP is a highly prevalent condition across the world with limited
treatment options. Lack of treatments lead to LBP being a
significant drain on medical resources. LBP is likely initiated by
damage-triggered innate immune responses by the resident cells
of the IVD, however this is not well understood, nor how this
innate immune response affects IVD biomechanics. This projects
looks to integrate both cellular and biomechanical components to
better understand this phenomenon.
2. Main findings:
a. Pure AF and NP cells can be successfully cultured, in vitro, from
the rat tail.
b. AF and NP cells have similar but unique PRR expression profiles
c. Both AF and NP cells respond to PAMPs and DAMPs specific to
TLR2/4, namely LPS and decorin respectively.
d. When stimulated with LPS and decorin, AF and NP cells produce
cytokines and chemokines AF and NP cells consistently produced
increased levels of IL-6 and MIP-2. AF cells also produced RANTES
and MCP-1, though RANTES upregulation in NP cells was
stimulant dependent. NP cells also did not upregulate MIP-2, and
TNF-α levels were not upregulated in either cell type.
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e. Decorin caused increased laxity in IVD biomechanics at 6d but not
24h post exposure, suggesting resident cell inflammation causes
IVD ECM degradation.
3. Implications of findings:
a. Blocking TLR2/4 signaling may be a viable therapeutic strategy for
treating LBP by reducing inflammation at its source.
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5. Appendices
Appendix A – Primary Cell Culture
F-12K Growth Media (For NR8383 Cells)
This will yield 500mLs of F-12K growth media with 15% FBS, 1% PenicillinStreptomycin and 25mM HEPEs
You Will Need:
1. 1x500mL bottle of F-12K media (Kaighn’s modification of Ham’s F-12 growth
media supplemented with 2mM L-glutamine and 1500mg/L sodium
bicarbonate (ATCC, Purchased through Cedarlane, Burlington Ont. Canada,
Catalogue # 30-2004)
2. 75mL of Heat Inactivated Fetal Bovine Serum (FBS) (Sigma-Aldrich, St.Louis,
Missouri, USA, Catalogue # F6178)
3. 5mLs of 100U/mL Penicillin /100 μg/mL Streptomycin Antibiotics (Fisher
Scientific, Fiarlawn, NJ, USA)
4. 12.5mLs of 1M sterile filtered HEPEs free acid (pH 7.4)
In aseptic conditions remove 87.5mls of F-12K media and store in 50ml falcon tubes
at 4oC for later use.
Add 75mLs of FBS, 5mLs of Pen-Strep solution and 12.5mLs of 1M HEPEs.
Mix and store at 4oC until needed.
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DMEM Growth Media (For AF Cells)
This will yield 500mLs of DMEM growth media with 10% FBS, 1% PenicillinStreptomycin and 25mM HEPEs
You Will Need:
1. 1x500mL bottle of Dulbecco’s Modified Eagle Medium (DMEM) (ATCC,
Purchased through Cedarlane, Burlington Ont. Canada, Catalogue # 30-2002)
2. 50mL of Fetal Bovine Serum (FBS) (Sigma-Aldrich, St.Louis, Missouri, USA,
Catalogue # F6178)
3. 5mLs of 100U/mL Penicillin /100 μg/mL Streptomycin Antibiotics (Fisher
Scientific, Fiarlawn, NJ, USA)
4. 12.5mLs of 1M sterile filtered HEPES free acid (pH 7.4)
In aseptic conditions remove 62.5mls of DMEM media and store in 50ml falcon
tubes at 4oC for later use.
Add 50mLs of FBS, 5mLs of Pen-Strep solution and 12.5mLs of 1M HEPEs.
Mix and store at 4oC until needed.
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RPMI Growth Media (For NP Cells)
This will yield 500mLs of RPMI growth media with 10% FBS, 1% PenicillinStreptomycin and 25mM HEPEs
You Will Need:
1. 1x500mL bottle of RPMI Medium 1640 (Gibco, Fisher Scientific, Fairlawn, NJ,
USA, Catalogue # A10491-01) with: • 4.5g/L D-Glucose
• 2.383 g/L HEPES Buffer
• L-Glutamine
• 1.5g/L Sodium Bicarbonate
• 110mg/L Sodium Pyruvate
2. 50mL of Fetal Bovine Serum (FBS) (Sigma-Aldrich, St.Louis, Missouri, USA,
Catalogue # F6178)
3. 5mLs of 100U/mL Penicillin /100 μg/mL Streptomycin Antibiotics (Fisher
Scientific, Fiarlawn, NJ, USA)

In aseptic conditions remove 50mls of RPMI media and store in a 50ml falcon tube
at 4oC for later use.
Add 50mLs of FBS and 5mLs of Pen-Strep solution.
Mix and store at 4oC until needed.
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Appendix B – PCR
B1. RNA Extraction
RNA extraction was performed from cell culture using the Sigma GeneElute
Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, St Louis, Missouri, USA,
Catalogue #RTN70-1KT)
Cells were detached using standard Trypsin-EDTA and pelleted before being
processed using the RNA kit.

Preparation Instructions
Before beginning the procedure, prepare the following:
1. Prepare the Lysis Solution/2-ME Mixture
Add 2-mercaptoethanol (2-ME) (M3148) to a volume of Lysis Solution (L8285)
sufficient for that day’s use, usually 500 μL of Lysis Solution/2-ME Mixture per RNA
preparation. 2-ME is required to fully inactivate RNases. Add 10 μL of 2-ME for each
1 mL of Lysis Solution.
2. Dilute Wash Solution 2 Concentrate
Dilute the Wash Solution 2 Concentrate (W3261) with 10 mL (10 prep package), 60
mL (70 prep package), or 300 mL (350 prep package) of 200 proof ethanol (E7023).
After each use, tightly cap the diluted Wash Solution 2 to prevent evaporation of the
ethanol.

Procedure
All steps are carried out at room temperature except where otherwise noted. Please
note that centrifugation speeds are given in units of g. Convert to rpm depending on
size of centrifuge rotor, according to the formula:
RCF = 1.118 × 10-5 × radius (in cm) × rpm2
where RCF = gravitational acceleration in units of g. If centrifuges/rotors for the
required g-forces are not available, use the maximum g-force possible and increase
the spin time proportionally. Spin until all liquid passes through column.
A. Cell Preparation
For best yields of intact RNA use only rapidly growing cells before they reach their
maximum density.
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1a. Harvest Cells
• Suspension cell cultures: Pellet up to 1 ×107 cells for 5 minutes at 300 × g. Remove
the culture medium completely and discard. Continue with step 2a.
• Attached cell cultures: Attached cells can be lysed directly in culture vessels or
released with trypsin and pelleted before lysis. To lyse cells directly, remove culture
medium completely, then continue with step 2a. Alternatively, trypsinize and pellet
cells using standard methods and proceed as for suspension cultures.
2a. Lyse cells and inactivate RNase
This is a critical step that must be accomplished quickly and thoroughly. The
resulting lysate may be stored at –70 °C for several months.
• Pelleted cells: Vortex pellet to loosen cells. Add 250 μL of the Lysis Solution/2-ME
Mixture for up to 5 × 106 cells or 500 μL of the Lysis Solution/2-ME Mixture for 5 ×
106 to 1 × 107 cells. Vortex or pipette thoroughly until all clumps disappear.
Continue with step 3a.
3a. Filter lysate
This step removes cellular debris and shears DNA, and may be omitted with fewer
than 106 cultured cells. Assemble a filtration column (CP9346) with a 2 mL
collection tube (T5449). Carefully pipette the lysed cells from step 2a
onto the filtration column. Centrifuge at maximum speed (12,000–16,000 × g) for 2
minutes. Discard the filtration column.
4a. Prepare for binding
Add an equal volume of 70% ethanol solution (500 μL) to the filtered lysate. Vortex
or pipette thoroughly to mix. Continue to Section D.

D. RNA Isolation
This is a continuation of the procedure from the samples prepared in Sections A
1d. Load lysate into binding column
Assemble a binding column (CP9471) with a 2 mL collection tube (T5449). Pipette
700 uL of the lysate/ ethanol mixture from step 4a, 4b or 6c onto the binding
column. If the volume of lysate/ethanol mixture is greater than 700 μL, the RNA
must be bound to the column in 2 steps. Centrifuge at maximum speed for 15
seconds. Discard the flow-through liquid, but retain the collection tube. Return the
binding column to the collection tube and apply any remaining lysate/ethanol
mixture to the column. Repeat the centrifugation as described above. Discard the
flow-through liquid, but retain the collection tube.
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2d. On Column DNase I Digestion
1. Pipette 250 μL of Wash Solution 1 into the column and centrifuge at maximum
speed for 15 seconds.
2. Mix 10 μL of DNase I (D2816) with 70 μL of DNase Digest Buffer (D1566) for each
preparation. Mix by inversion. Do not vortex the DNase I or the DNase I/Digest
Buffer mixture. DNase I is sensitive to physical denaturation.
3. Add 80 μL of the DNase I/Digest Buffer mixture directly onto the center of the
Binding Column.
5. Incubate at room temperature for 15 minutes.
6. Pipette 250 μL of Wash Solution 1 into the column and centrifuge at maximum
speed for 15 seconds. This is a critical step. Omission may result in 20–80% loss of
RNA.
7. Transfer the binding column into a fresh 2.0 mL collection tube, and continue with
Section D, step 3.
3d. Second column wash
Transfer the binding column into a fresh 2 mL collection tube. Discard the flowthrough liquid and the original collection tube. Ensure that Wash Solution 2
Concentrate (W3261) has been diluted with ethanol as described in the Preparation
Instructions. Pipette 500 μL of this ethanol containing Wash Solution 2 into the
column and centrifuge at maximum speed for 15 seconds. Discard the flow- through
liquid, but retain the collection tube.
4d. Third column wash
Pipette a second 500 μL volume of Wash Solution 2 into the column and centrifuge
at maximum speed for 2 minutes to dry the binding column.
Optional spin to further dry the column. The binding column must be free of
ethanol before eluting the RNA. Centrifuge the column for an additional 1 minute at
maximum speed if any residual Wash Solution 2 is seen on the surface of the binding
column. Empty and re-use the collection tube if you need this additional
centrifugation step.
5d. Elute RNA
Transfer the binding column to a fresh 2 mL collection tube. Pipette 50 μL of Elution
Solution (E8024) into the binding column and centrifuge at maximum speed for
1 minute. If greater than 50 μg of RNA is expected (see Expected Yield under
Results), repeat the elution with a second 50 μL volume of Elution Solution,
collecting both eluates in the same tube. Purified RNA is now in the flow-through
eluate (~45 or 90 μL total), and is ready for immediate use or storage at –70 °C.
Keep the RNA on ice whenever it is thawed for use
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B2. cDNA Synthesis – iScript
RNA collected from the GeneElute Mammalian Total RNA MiniPrep Kit was
quantified using the Thermo Scientific NanoDrop Lite Spectrophotometer.
1. Put RNA, iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad
Laboratories, Mississauga, Ont, Canada, Catalogue #1708840), and DNA
Quality Water on ice.
2. Combine 1ug of RNA, 4ul iScript Supermix, and enough DNA quality H2O to
make 20ul total volume.
3. Place tubes in thermocycler and use the iScript protocol listed below
1. 25oC for 5:00 minutes
2. 46oC for 20:00 minutes
3. 95oC for 1:00 minute
4. 4oC for ∞
Keep all cDNA at 4oC until needed and store at -20oC if long-term storage is
necessary.
Unused RNA should be stored at -80oC until required for cDNA synthesis and freeze
thawing should be avoided
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B3. RT-PCR – GoTaq
1. Thaw GoTaq Green 2x Master Mix (Promega Corporation, Madison, WI, USA,
Catalogue # M712B) and RT-PCR Primers.
2. Place cDNA, DNA Quality Water, Primers, and GoTaq Master Mix on ice.
3. Mix appropriate volumes of cDNA, water, forward and reverse primers and
master mix according to manufacturers specification.
4. ½ reaction volumes (12ul) were used to screen PCR products with larger
volumes being produced and purified for sequencing purposes.
5. Samples were placed in the thermocycler after PCR contents were mixed and
spun down. Samples were run through the following protocol as all target
PCR products were under 1kB is size.
1. 95oC – 2 minutes
2. 95oC – 45 seconds
3. 50 -55oC – 60 seconds (exact annealing temperature was optimized for each
set of primers)
4. 72oC - 1 minute
Repeat steps 2-4 34x
5. 72oC - 10 minutes
6. 4oC - ∞
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B4. Gel Electrophoresis
Gels are prepared based on the number of samples being screened. Generally
screening of PRR profiles was completed using a medium sized gel (20 Wells)
1. Mix together appropriate amounts of agarose (Bio-Rad Laboratories,
Hercules, CA, USA, Catalogue # 61-3101) and 1xTAE buffer in a bench
pint based on the following combinations to make a 1% agarose gel. If
PCR products are particularly small < 300bp, better resolution between
product sized can be obtained by increasing the agarose concentration
from 1.5-2.0%
. Small gel (8 wells) – 0.4g agarose + 40mL 1x TAE buffer
. Medium gel (20 wells) – 1g agarose + 100mL 1x TAE buffer
. Large gel (40 wells) – 2g agarose + 200mL 1x TAE buffer
2. Close bottle with a vented lid and heat in microwave mixing every 30
seconds until the agarose completely dissolves.
3. Pour gel into a leveled gel caster; comb out any bubbles in the gel using
the gel comb to rake them to the bottom of the gel. Place comb in the
groove slots.
4. Allow gel to fully solidify
5. Place gel and caster in rig filled with buffer then remove the comb.
6. Turn on power pack, set voltage to 110 volts and time to 1hr (voltage and
run times may vary based on gel size, product size and the level of
resolution between PCR products required)
7. Load samples leaving 1 well for a gene ruler of your choice
8. Let gel run
9. Once gel has finished running take gel and place it in EtBr stain (0.5
μg/mL EtBr in MilliQ water) for 10 minutes.
10. Destain in MilliQ water for a minimum of 20 minutes
11. Image gel under camera capable of UV trans illumination such as a BioRad Versa doc. or other suitable imager. Exact exposure times will vary
depending on exact equipment specifications.
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Appendix C – Multiplex

Figure 17: Multiplex Protocol
Multiplex protocol used to determine the concentration of several cytokines from a
single 50ul sample. 1) Magnetic beads with various capture antibodies are mixed
together depending on which cytokines will be tested for. The bead mixture are
pipetted into each well of a 96 well plate. 2) The plate is placed in a magnetic holder
that holds the beads in place then each well is washed three times with wash buffer
to remove unbound beads from the wells. 3) Serial dilutions are prepared from
stock samples of each cytokine being tested and pipetted into individual wells on
the plate in duplicate. 4) Media samples containing the cytokines being tested are
also plated and allowed to incubate for 1hour. The wells are washed three times
with wash buffer to remove unbound sample. 5) Biotinylated detection antibodies
are added to each well and allowed to incubate for 30 minutes. Unbound detection
antibodies are washed away by again washing each well three times with wash
buffer. 6) Streptavidin is added to amplify the signal from the biotinylated detection
antibodies. 7) This results in the antigen being sandwiched between the magnetic
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bead and streptavidin signal. 8) This complex is detected and quantified by
comparing the data from the standards and samples allowing us to determine the
concentration of each cytokine at various stages of the innate immune response
after challenging each cell line with different danger associated molecules.
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